1 / 7
- Slide 1: OUTCOMES & HOME IRRIGATION | Hirschsprung Disease | Postoperative outcomes and home irrigation protocols for Hirschsprung disease management | Cincinnati Children's
- Slide 2: OUTCOMES & HOME IRRIGATION | Hirschsprung Disease | Postoperative outcomes and home irrigation protocols for Hirschsprung disease management | Cincinnati Children's
- Slide 3: HIGH-FREQUENCY EMS UTILIZATION | PATTERNS & INSIGHTS | ESO Data Collaborative Analysis | Characteristics of patients who frequently access emergency medical services | Resource allocation strategies for prehospital care systems
- Slide 4: OUTCOMES & HOME IRRIGATION | Hirschsprung Disease | Postoperative outcomes and home irrigation protocols for Hirschsprung disease management | Cincinnati Children's
- Slide 5: OUTCOMES & HOME IRRIGATION | Hirschsprung Disease | Postoperative outcomes and home irrigation protocols for Hirschsprung disease management | Cincinnati Children's
- Slide 6: GCMD LIBRARY | HIRSCHSPRUNG DISEASE | OPTIMAL TIMING FOR SURGERY | Key Considerations | Infant age and weight | Disease severity and extent | Nutritional status | Presence of complications | Surgical expertise available | Timing Recommendations | Early repair (2-6 months) preferred when: | Adequate weight gain achieved | No active enterocolitis | Experienced surgical team available | Delayed repair may be needed for: | Premature infants | Severe malnutrition | Active infection or enterocolitis | Limited surgical resources | Clinical Outcomes | Earlier surgery associated with: | Shorter hospital stays | Fewer postoperative complications | Better long-term bowel function | Improved quality of life | Individualized approach essential | Multidisciplinary team decision-making | Cincinnati Children's
- Slide 7: GCMD LIBRARY | HIRSCHSPRUNG DISEASE | BOTOX INJECTION AT TIME OF PULL-THROUGH | REVIEW OF THE LITERATURE | Hirschsprung disease is a congenital condition characterized by the absence of ganglion cells in the distal colon, leading to functional obstruction. The definitive treatment is a pull-through procedure, which involves resecting the aganglionic segment and anastomosing healthy bowel to the anus. | BOTOX INJECTION | Some surgeons inject botulinum toxin (Botox) into the internal anal sphincter during the pull-through to reduce sphincter tone and potentially improve outcomes. | CURRENT EVIDENCE | Recent systematic reviews and meta-analyses have examined whether Botox injection at the time of pull-through improves postoperative outcomes in Hirschsprung disease. | KEY FINDINGS | Studies show mixed results regarding the benefit of Botox injection. Some report reduced rates of enterocolitis and obstructive symptoms, while others find no significant difference in outcomes compared to pull-through alone. | CLINICAL PRACTICE | The decision to use Botox remains surgeon-dependent and institution-specific. There is no universal consensus, and practice varies widely across pediatric surgery centers. | CONCLUSION | While Botox injection during pull-through for Hirschsprung disease is used by some surgeons, the current evidence does not definitively support its routine use. Further high-quality randomized controlled trials are needed to establish clear guidelines. | Cincinnati Children's
Refractory Chronic Pancreatitis: Partial Resection or Total Pancreatectomy?
Topic overview
Educational carousel comparing surgical approaches for refractory chronic pancreatitis in children. Reviews indications for partial versus total pancreatectomy, including consideration of islet autotransplantation to preserve endocrine function when complete resection is required.
Comments